REVBW

Conviction 14HealthcareScan · Thu, Jun 25, 2026

REVBW$0.0066+0.00%

ResistanceSupportVol 14

Vol MA14 25.77K

Mar 26Apr 14May 1May 19Jun 8Jun 25

REVELATION BIOSCIENCES, INC.PHARMACEUTICAL PREPARATIONSwww.revbiosciences.com ↗

Price0.0066

Change+0.00%

Gap—

Rel volume0.82×

Avg volume23.73K

Avg $ vol269.14

SMA 200.0094

SMA 500.0082

SMA 2000.0077

Price vs 50-19.86%

Price vs 200-14.32%

MA stackmixed

50/200 crossgolden · 9d

Supertrenddown · 0.0162

RSI (14)49

MACD hist-0.00

MACD cross—

Stoch %K / %D53 / 39

ADX (14)25

+DI / −DI43 / 30

RSI divergence—

MACD divergence—

ATR %+98.05%

ADR %22.94%

52w high0.0198

52w low0.0000

From 52w high-66.67%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width185.92%

%B0.34

Donchian pos44.30%

Donchian high0.0149

Donchian low0.0000

AVWAP (52w high)0.0186

vs AVWAP high-64.51%

AVWAP (52w low)0.0135

vs AVWAP low-51.06%

OBV trendUp

Chaikin MF (20)0.54

Today vs 20d0.82×

Avg vol (14d)25.77K

Avg vol (20d)23.73K

Avg $ vol (20d)269.14

Market cap25.8K

RS 3m (vs SPY)—

RS 6m (vs SPY)-107.74%

RS line new highNo

Trend template0/7

Technical rank15.4

1 week-43.10%

1 month-44.07%

3 months—

6 months-19.51%

1 year-44.07%

YTD—

P/E-0.00

P/B0.00

P/S—

P/FCF-0.00

EPS-23.95

Div yield—

ROE-68.62%

ROA-59.25%

Debt/Eq—

Current10.02

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth40.73%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-14.09M

Revenue—

Net income-3.01M

Gross profit—

Free cash flow-8.29M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees9

ListedTue, Jan 11, 2022

Free float3.91M

Float %100.0%

Short interest3.31K

Days to cover0.0d

Short volume0.9%

Squeeze score0 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction14 / 100

Pattern quality—

Tech rank15.4 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.0295

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in REVBW

All disclosures →

No recent disclosed trades by Congress in REVBW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in REVBW

No recent insider (Form 4) filings in REVBW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in REVBW

EDGAR →

No recent SEC filings on file for REVBW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.